Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

DSGN · Insider trading · 13F holders · Congress trades

Design Therapeutics, Inc. (DSGN)

Who is buying and selling DSGN: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.

13F filers holding
14
Insider buys, 90 days
$0
Insider sales, 90 days
$0
Congress trades, 12 months
0

DSGN at a glance

  • No open-market insider purchases or sales of DSGN were filed in the last 90 days.
  • 14 13F filers hold DSGN among their 50 largest positions, worth $307.7M combined, including Julian and Felix Baker. The biggest bets by portfolio weight are SR One Capital Management, LP (9.1%), Trails Edge Capital Partners, LP (4.6%) and Almitas Capital LLC (3.6%). In their latest 13Fs, 2 managers opened a new position and 3 added to one.
  • No member of Congress has disclosed a trade in DSGN.

DSGN insider trading

No open-market insider purchases or sales of DSGN were filed in the last 90 days.

Who owns DSGN? Hedge funds and superinvestors

14 13F filers hold DSGN among their 50 largest positions, worth $307.7M combined, including Julian and Felix Baker. The biggest bets by portfolio weight are SR One Capital Management, LP (9.1%), Trails Edge Capital Partners, LP (4.6%) and Almitas Capital LLC (3.6%). In their latest 13Fs, 2 managers opened a new position and 3 added to one.

Superinvestors holding DSGN: Julian and Felix Baker 0.2%

13F filers holding DSGN
Manager% of portfolioValueSharesLast quarter13F
SR One Capital Management, LPHedge fund9.1%$94.4M6,526,476+0.0% sharesQ2 2026
Logos Global Management LPHedge fund1.9%$43.4M3,000,000+53.8% sharesQ2 2026
Julian and Felix BakerHedge fund0.2%$38.8M2,678,430+3.6% sharesQ2 2026
Trails Edge Capital Partners, LPHedge fund4.6%$29.0M2,001,282+134.9% sharesQ2 2026
Frazier Life Sciences Management, L.P.Hedge fund0.6%$26.2M1,809,854NewQ2 2026
Vivo Capital, LLCHedge fund2.1%$23.3M1,612,903+0.0% sharesQ2 2026
Caption Management, LLCHedge fund0.6%$16.2M1,118,098—Q2 2026
Almitas Capital LLCHedge fund3.6%$14.9M1,026,893-32.9% sharesQ2 2026
Sofinnova Investments, Inc.Hedge fund0.7%$12.5M865,135—Q2 2026
Acuta Capital Partners, LLCHedge fund2.8%$4.1M282,564+93.7% sharesQ2 2026
KVP Capital Advisors, LPHedge fund2.0%$2.7M185,000NewQ2 2026
Elmind Capital, LPHedge fund0.4%$1.6M107,900-48.1% sharesQ2 2026
Verdad Advisers, LPAsset manager0.7%$688K47,557-48.5% sharesQ2 2026
Caz Investments LPHedge fund0.1%$51K3,500+0.0% sharesQ2 2026

Each manager counts with its latest 13F (Q2 2026: 14). Screen DSGN in the grand portfolio →

DSGN stock trades by members of Congress

No member of Congress has disclosed a trade in DSGN.

DSGN questions and answers

Are insiders buying DSGN stock?

No open-market insider purchases or sales of DSGN were filed in the last 90 days.

Which hedge funds own DSGN?

14 13F filers hold DSGN among their 50 largest positions, worth $307.7M combined, including Julian and Felix Baker. The biggest bets by portfolio weight are SR One Capital Management, LP (9.1%), Trails Edge Capital Partners, LP (4.6%) and Almitas Capital LLC (3.6%). In their latest 13Fs, 2 managers opened a new position and 3 added to one.

Has Congress traded DSGN?

No member of Congress has disclosed a trade in DSGN.

Who is the largest holder of DSGN?

Among 13F filers, SR One Capital Management, LP reports the largest DSGN position, $94.4M (6,526,476 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is SR One Capital Management, LP's: 9.1% of its portfolio.

Cite or share this

Free to use with a link back. The data updates every filing day.

Citation
Link